Health News
Low Blood Pressure During Dialysis May Lead to Clots
It's been known that low blood pressure while undergoing kidney dialysis is linked to some nasty side effects. Now the risk of blood clots has been added to that expanding list.
The Risks of Rural Life
It seems so idyllic - the farm life does. Yet new research finds that children who grew up on a livestock farm are at greater risk for developing certain types of cancer.
Rare Blood Disorder Gene Found
Some diseases are so rare that even figuring out how to diagnose them can be tricky. The discovery of a gene for an extremely rare blood disorder could help make it easier to diagnose through DNA testing.
Genetic Maps of African Americans
Certain congenital diseases such as sickle cell anemia predominantly affect blacks. The University of Oxford constructed the first detailed genetic map from African American genetic information that may allow for better treatment of such diseases.
Blood Cleaning Provides New Transplant Options
Finding a transplant match is no easy task. In addition to organ size and donor age, blood types must also match. A novel procedure may make the blood type issue a thing of the past.
Clues to Blood Clotting
Evolutionary clues have led scientists to a discovery of how a key clotting protein assembles. This could aid in better understanding, and possibly treatments for common bleeding disorders.
FDA Drug Safety Communication: Revlimid
The U.S. Food and Drug Administration (FDA) is informing the public that we are aware of results from clinical trials conducted inside and outside the United States that found that patients treated with Revlimid ( lenalidomide ) may be at an increased risk of developing new types of cancer compared to patients who did not take the drug.
FDA is currently reviewing all available information on this potential risk and will communicate any new recommendations once it has completed its review.
At this time, FDA recommends that patients continue their Revlimid treatment as prescribed by their...
FDA Drug Safety Communication: TNF blockers
The U.S. Food and Drug Administration (FDA) is informing the public that it continues to receive reports of a rare cancer of white blood cells (known as h epatosplenic T-Cell lymphoma or HSTCL ), primarily in adolescents and young adults being treated for Crohn’s disease and ulcerative colitis with medicines known as tumor necrosis factor ( TNF ) blockers, as well as with azathioprine , and/or mercaptopurine .
Crohn's disease and ulcerative colitis cause inflammation of the digestive system. Common symptoms are pain in the abdomen, cramps, and diarrhea. Bleeding from the rectum, wei...
CML Hope After all Else has Failed
Leukemia begins in the bone marrow. Medications can treat most forms of this cancer, but drugs don't work for everyone. Scientists are trying to find new answers – and hope.
TB Blood Tests Inaccurate
Blood tests are one method that has been relied on to diagnosis tuberculosis (TB). Now the World Health Organization has warned that such blood tests can frequently be inaccurate and lead to unsuitable treatments.